Gianluca Nucci, Pfizer
personal info
I am the Head of PRD Clinical Pharmacology at Pfizer.
My team is accountable for the clinical pharmacology input, interpretation, strategy, and execution at all stages of development in the non-oncology therapeutic areas. The group provides end to end clinical pharmacology leadership to integrate PK, PD, patient characteristics and disease biology to inform translational and clinical development strategies, driving robust decisions and regulatory interactions with innovative study/program design and model informed drug discovery/development.
The goal is to have quantitative clinical pharmacology considerations in each program and at all stages of development: driving clinical and translational pharmacology plans as well as efficient trial design and analysis using all available data and quantitative knowledge management tools.
I am an advocate for integrating PK-PD, systems modeling and literature meta-analysis to drive objective decisions and regulatory interactions. I am passionate about designing innovative, efficient Clinical Pharmacology studies, development programs and of close partnerships with clinical and nonclinical lines.